Immunofluorescence and confocal microscopy for ex‐vivo diagnosis of melanocytic and non‐melanocytic skin tumors: A pilot study

Background Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biophotonics Vol. 11; no. 3
Main Authors: Hartmann, Daniela, Krammer, Sebastian, Vural, Secil, Bachmann, Mario Raphael, Ruini, Cristel, Sárdy, Miklós, Ruzicka, Thomas, Berking, Carola, von Braunmühl, Tanja
Format: Journal Article
Language:English
Published: Weinheim WILEY‐VCH Verlag GmbH & Co. KGaA 01.03.2018
Wiley Subscription Services, Inc
Subjects:
Antibodies
basal cell carcinoma
Confocal microscopy
Diagnosis
diagnostics in dermatology
Dilution
Fluorescence
fluorescence confocal microscopy
Histopathology
Immunofluorescence
Immunohistochemistry
Lasers
melanoma
metastasis
Microscopy
Protocol
Reflectance
Scanning microscopy
Skin
Skin cancer
skin surgery
skin tumors
Tumors
diagnostics in dermatology
metastasis
fluorescence confocal microscopy
basal cell carcinoma
melanoma
skin surgery
skin tumors
immunofluorescence
ISSN:1864-063X, 1864-0648, 1864-0648
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex‐vivo CLSM. Methods The tissue probes from various skin tumors were stained with FITC‐labeled S‐100A10, Melan‐A and anti‐Ber‐EP4 antibodies before examination with ex‐vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex‐vivo CLSM. Results S100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber‐EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results. Conclusion The use of fluorescent‐labeled antibodies in ex‐vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors. Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) enables intraoperative tissue diagnostics on a level equivalent to histopathology. Tissue probes from melanoma, melanocytic nevus, basal and squamous cell carcinoma were stained with FITC‐labeled S100, Melan A and Ber‐EP4 antibodies. S100 immunostaining was successful in 55.6%, Melan A in 66.7% and Ber‐EP4 in 85.7%. In combination with the application of fluorescent dyes, ex‐vivo CLSM offers unique possibilities of rapid tissue examination.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1864-063X
1864-0648
1864-0648
DOI:10.1002/jbio.201700211